Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Emblon 10mg tablets
0803041S0BJABAA
|
Emblon | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Encorafenib 50mg capsules
0801050CMAAABAB
|
Encorafenib | Encorafenib | Malignant Disease and Immunosuppression | No data available |
|
Encorafenib 75mg capsules
0801050CMAAAAAA
|
Encorafenib | Encorafenib | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 1g powder for solution for injection vials
0801010H0BBAFAD
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 200mg powder for solution for injection vials
0801010H0BBADAB
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 500mg powder for solution for injection vials
0801010H0BBAEAC
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 50mg tablets
0801010H0BBABAF
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Enzalutamide 40mg capsules
0803042U0AAAAAA
|
Enzalutamide | Enzalutamide | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 100mg/50ml solution for infusion vials
0801020N0AAAGAG
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg powder for solution for injection vials
0801020N0AAAAAA
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg/5ml solution for injection vials
0801020N0AAADAD
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 200mg/100ml solution for infusion vials
0801020N0AAAFAF
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg powder for solution for injection vials
0801020N0AAABAB
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg/10ml solution for injection vials
0801020N0AAAIAI
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg powder for solution for injection vials
0801020N0AAACAC
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg/25ml solution for injection vials
0801020N0AAAEAE
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Eposin 100mg/5ml concentrate for solution for infusion vials
0801040D0BCAAAD
|
Eposin | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Eposin 500mg/25ml concentrate for inf vials
0801040D0BCABAF
|
Eposin | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Erbitux 100mg/20ml solution for infusion vials
0801050AGBBABAB
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
|
Erbitux 100mg/50ml solution for infusion vials
0801050AGBBAAAA
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
|
Erbitux 500mg/100ml solution for infusion vials
0801050AGBBACAC
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
|
Eribulin 1320micrograms/3ml solution for injection vials
0801050BBAAABAB
|
Eribulin | Eribulin | Malignant Disease and Immunosuppression | No data available |
|
Eribulin 880micrograms/2ml solution for injection vials
0801050BBAAAAAA
|
Eribulin | Eribulin | Malignant Disease and Immunosuppression | No data available |
|
Erivedge 150mg capsules
0801050BMBBAAAA
|
Erivedge | Vismodegib | Malignant Disease and Immunosuppression | No data available |
|
Erleada 240mg tablets
0803042V0BBABAB
|
Erleada | Apalutamide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.